UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 393

Sortiert nach

1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors

Annals of oncology, 2023-10, Vol.34, p.S623-S624

2023

Volltextzugriff (PDF)

169P Immunomodulatory effects of RBS2418, an oral ENPP1 inhibitor in combination with pembrolizumab in checkpoint-refractory metastatic adrenal cancer

Immuno-oncology technology, 2022-12, Vol.16, p.100281, Article 100281

2022

Volltextzugriff (PDF)

195TiP A first-in-human, phase I a/b dose escalation and expansion study to evaluate RBS2418 as monotherapy and in combination with pembrolizumab in subjects with advanced unresectable, recurrent or metastatic tumors

Immuno-oncology technology, 2022-12, Vol.16, p.100307, Article 100307

2022

Volltextzugriff (PDF)

221

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S122

2006

Volltextzugriff (PDF)

221: Use of Aromatase Inhibitors as Radiosensitizing and Therapeutic Agents in the Treatment of Human Pancreatic, Glioblastoma and Lung Cancer

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S122-S122

2006

Volltextzugriff (PDF)

232TiP KEYNOTE-061: Pembrolizumab (MK-3475) versus paclitaxel as second-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma

Annals of oncology, 2015-12, Vol.26, p.ix42-ix42

2015

Volltextzugriff (PDF)

2644

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S568-S569

2006

Volltextzugriff (PDF)

2644: Use of Aromatase Inhibitors as Radiosensitizing and Therapeutic Agents in the Treatment of Human Pancreatic, Glioblastoma and Lung Cancer

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S568-S569

2006

Volltextzugriff (PDF)

The 4-nitrobenzenesulfonyl group as a convenient N-protecting group for iminosugars—synthesis of oligosaccharide inhibitors of heparanase

Tetrahedron letters, 2010-01, Vol.51 (2), p.391-395

2010

Volltextzugriff (PDF)

412 PREVALENCE, VIROLOGICAL AND CLINICAL CHARACTERISTICS OF CHRONIC HEPATITIS DELTA VIRUS INFECTION (CHD) IN ROMANIA

Journal of hepatology, 2013-04, Vol.58, p.S169-S169

2013

Volltextzugriff (PDF)

453 Personalized DNA neoantigen vaccine (GNOS-PV02) in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A481-A481

2021

Volltextzugriff (PDF)

830PSynthetic DNA immunotherapy in biochemically relapsed prostate cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

924P SNS-301 added to pembrolizumab in patients (Pts) with ASPH+ advanced squamous cell carcinoma of the head & neck (SCCHN)

Annals of oncology, 2020-09, Vol.31, p.S666-S666

2020

Volltextzugriff (PDF)

aberrant island-dwelling theropod dinosaur from the Late Cretaceous of Romania

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (35), p.15357-15361

2010

Volltextzugriff (PDF)

Abstract 1454: Long-term immunogenicity results from a first-in-human study evaluating the anti-ASPH cancer vaccine, SNS-301

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1454-1454

2019

Volltextzugriff (PDF)

Access to peginterferon plus ribavirin therapy for hepatitis C in Romania between 2002-2009

Journal of gastrointestinal and liver diseases : JGLD, 2010-06, Vol.19 (2), p.161-167

2010

Volltextzugriff (PDF)

Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification

Frontiers in pharmacology, 2024-07, Vol.15

2024

Volltextzugriff (PDF)

AGRICULTURAL LAND AND ACTIVITIES IN MUREȘ COUNTY

Analele Universităţii din Oradea. Seria Geografie, 2019-12, Vol.29 (2), p.114-123

2019

Volltextzugriff (PDF)

Alexithymia and emotion regulation in patients with Raynaud's disease

Journal of clinical psychology, 2020-09, Vol.76 (9), p.1696-1704

2020

Volltextzugriff (PDF)

The Allen Test

The Annals of thoracic surgery, 2005-02, Vol.79 (2), p.755-755

2005

Volltextzugriff (PDF)

AMBULATORY BLOOD PRESSURE VARIABILITY- THE HIGHER THE WORST?

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e268

2018

Volltextzugriff (PDF)

America First

Nemzet és Biztonság : biztonságpolitikai szemle, 2018-01 (1), p.2-2

Tamás, Csiki Varga

2018

Volltextzugriff (PDF)

Az amerikai transznacionális vállalatok lokalizációja 1983 és 2007 között

Tér és társadalom, 2010-12, Vol.24 (4), p.267-284

Csiki, Anita

2010

Volltextzugriff (PDF)

Az amerikai transznacionális vállalatok térszerveződése az 1990-es években

Tér és társadalom, 2004-09, Vol.18 (3), p.91-110

Csiki, Anita

2004

Volltextzugriff (PDF)

Anti-Vascular Endothelial Growth Factor Treatment in Combination with Chemotherapy Delays Hematopoietic Recovery Due to Decreased Proliferation of Bone Marrow Hematopoietic Progenitor Cells

Journal of thoracic oncology, 2010-09, Vol.5 (9), p.1410-1415

2010

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(313)
Mit Volltextzugriff
(331)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors

169P Immunomodulatory effects of RBS2418, an oral ENPP1 inhibitor in combination with pembrolizumab in checkpoint-refractory metastatic adrenal cancer

195TiP A first-in-human, phase I a/b dose escalation and expansion study to evaluate RBS2418 as monotherapy and in combination with pembrolizumab in subjects with advanced unresectable, recurrent or metastatic tumors

221

221: Use of Aromatase Inhibitors as Radiosensitizing and Therapeutic Agents in the Treatment of Human Pancreatic, Glioblastoma and Lung Cancer

232TiP KEYNOTE-061: Pembrolizumab (MK-3475) versus paclitaxel as second-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma

2644

2644: Use of Aromatase Inhibitors as Radiosensitizing and Therapeutic Agents in the Treatment of Human Pancreatic, Glioblastoma and Lung Cancer

The 4-nitrobenzenesulfonyl group as a convenient N-protecting group for iminosugars—synthesis of oligosaccharide inhibitors of heparanase

412 PREVALENCE, VIROLOGICAL AND CLINICAL CHARACTERISTICS OF CHRONIC HEPATITIS DELTA VIRUS INFECTION (CHD) IN ROMANIA

453 Personalized DNA neoantigen vaccine (GNOS-PV02) in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma

830PSynthetic DNA immunotherapy in biochemically relapsed prostate cancer

924P SNS-301 added to pembrolizumab in patients (Pts) with ASPH+ advanced squamous cell carcinoma of the head & neck (SCCHN)

aberrant island-dwelling theropod dinosaur from the Late Cretaceous of Romania

Abstract 1454: Long-term immunogenicity results from a first-in-human study evaluating the anti-ASPH cancer vaccine, SNS-301

Access to peginterferon plus ribavirin therapy for hepatitis C in Romania between 2002-2009

Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification

AGRICULTURAL LAND AND ACTIVITIES IN MUREȘ COUNTY

Alexithymia and emotion regulation in patients with Raynaud's disease

The Allen Test

AMBULATORY BLOOD PRESSURE VARIABILITY- THE HIGHER THE WORST?

America First

Az amerikai transznacionális vállalatok lokalizációja 1983 és 2007 között

Az amerikai transznacionális vállalatok térszerveződése az 1990-es években

Anti-Vascular Endothelial Growth Factor Treatment in Combination with Chemotherapy Delays Hematopoietic Recovery Due to Decreased Proliferation of Bone Marrow Hematopoietic Progenitor Cells

Suchergebnisse filtern